In 2013, Daiichi had launched the arbitration proceedings in Singapore.
Alkem Labs was issued drug alerts twice last year -- in June and July -- for its drug Glimekem.
The draft bill allows euthanasia for patients who can take informed decisions; doctors to be protected from liability.
Daiichi alleged that Singh brothers had concealed and misrepresented critical information concerning US Food and Drug Administration and Department of Justice investigations into Ranbaxy
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
NHAI to pull plug on Rs 3,000-crore ventures for poor show
Sanjeev Vashishta, chief executive officer at SRL Diagnostics, talks to Deepak Patel about expansion plans and regulations for the sector.
Govt bans brands with annual sales worth Rs 3,728 crore.
Between 2011 and 2014, they indirectly determined the price of tyres in the market, says report
Lobby group tells USTR it has got assurance from India on compulsory licensing.
A dialysis machine contributes only 6 per cent to the overall cost.
11 states were assessed for access to clean water, energy and sanitation and use of iodised salt.
The impact from NELM on the Indian pharmaceutical sector is estimated to be around Rs 6,000 crore.
The French drug maker has its vaccine approved in Mexico for all four serotypes for patients aged 9 to 45.
The BSE fined 370 listed companies following the Sebi notification.
RINL wiped out its losses in 2005-06 with money from the government.
New head of the Confederation of Indian Industry speaks.
Their coal block bids may be referred to CCI.
Currently there is no standard ideal debt to equity ratio.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances